Briovarx Infusion Services in Roseville, MN

Assisted Living communities with a similar price nearby

• About the same

  Highland on Graham

  4.9 from 29 reviews

  $3,000 to $4,000 / month

  8.6 miles away
• from -$300 / mo

  Trouvaille Memory Care Suites

  4.9 from 26 reviews

  $2,700 to $3,700 / month

  20.5 miles away
• from -$230 / mo

  MainStreet Lodge

  4.9 from 12 reviews

  $2,770 to $3,130 / month

  3.3 miles away
• from +$500 / mo

  Our Lady Of Peace Home Care

  4.8 from 80 reviews

  $3,500 to $6,000 / month

  4.8 miles away
• from -$200 / mo

  Trails of Orono

  4.7 from 101 reviews

  $2,800 to $3,790 / month

  16.8 miles away

Pros

• The pharmacy is open 24 hours a day.

Cons

• The pharmacy appears to have lost the ability to deliver infusions correctly.
• They repeatedly send the wrong quantities — four bottles with no supply kits, then 3.5 supply kits.
• Infusion deliveries have been delayed for two consecutive months, interrupting treatment.
• The pharmacist belittled the patient, called them condescending, and blamed the patient for the mistakes.
• The staff disregarded the patient and insisted the patient spell out every item needed for each weekly kit.
• The reviewer describes the pharmacy’s behavior as incompetence bordering on theft, including over-sent or forgotten medications.
• There is poor follow-through in customer service.
• The delays have put the patient’s life at risk due to a compromised immune system.
• Despite paying about $40,000 a month, the pharmacy requires the patient to call monthly to specify what goes into each kit.

Review

Briovarx Infusion Services in Roseville, MN is best suited for families and individuals who rely on steady, professionally coordinated infusion therapy and can prioritize a meticulous, error-averse delivery process. In particular, the community serves patients who need reliable kit fulfillment and clear, timely communication from a dedicated infusion team. When the operation runs as intended, Briovarx should appeal to those who want a straightforward, predictable regimen with an emphasis on accurate shipment of supplies and responsive support on infusion days.

That said, there are clear red flags that families should weigh carefully and may want to explore alternatives for. The strongest caveat is the risk of delivery and supply errors that translate directly into treatment interruptions. One pervasive review scenario describes multiple months of miscounts and missing components for infusion kits, with shipments arriving short of the required number of supply kits or missing entire items. In a regimen where weekly infusions are the norm, even small errors become life-altering, especially for patients with compromised immune systems who depend on consistent access to therapy. When delays or mispacks occur, the potential consequences extend from schedule disruption to serious health consequences.

The core pros, reliability, timely replenishment, and a respectful, patient-centered service model, must be delivered consistently to offset these risks. If Briovarx maintains rigorous inventory controls, automated order reconciliation, and a proactive customer-service culture, the positives can effectively counterbalance the downsides evidenced in the broader review set. A facility that can demonstrate near-perfect fulfillment rates, rapid correction of any misshipment, and a courteous, competent pharmacist or care coordinator on the line will outperform peers and reassure families who already carry high-risk health needs. Without those safeguards, however, the same gaps that appear in the negative experiences become operational realities.

The negative experience highlighted in the reviews underscores how quickly a lapse can escalate into a dangerous situation. A patient with a primary immunodeficiency reported repeated misses in shipments, missing supply kits, and a lack of accountability from frontline staff. The frustration turned personal and professional: calls to resolve the issue dragged on, and when disputes arose, patient concerns were dismissed rather than addressed. The result was not merely inconvenience but a formal threat to health that forced the patient to seek alternatives. This is the template families should use to stress-test Briovarx: what are the exact safeguards against persistent fulfillment errors, and what escalation pathway exists when a gap surfaces?

Families should press Briovarx for concrete assurances before committing. Key questions include: what is the current on-time delivery rate for infusion kits and supplies? what are the steps and timelines for correcting any missing items, and how quickly are replacements sent? Is there a dedicated case manager or point of contact who oversees each patient’s monthly supply cycle? what automation or double-check processes are in place to prevent human error in kit assembly and shipping? what are the patient-facing escalation options if a delivery problem recurs, and how are patients protected from health risks during delays? Finally, request transparent performance metrics and a service-level agreement that binds the facility to corrective actions and documented commitments.

In the end, Briovarx Infusion Services can be a strong choice for families who prioritize dependable logistics and compassionate, accessible support, and who insist on a rigorous, verifiable fulfillment system. If the operation demonstrates a track record of consistent accuracy, rapid problem resolution, and professional, respectful patient interactions, it stands as a solid option in a market where small lapses can have outsized consequences. If, however, these safeguards are not evident or proven, alternative providers with stronger, demonstrable reliability should be the default consideration. The decisive factor is whether Briovarx can translate procedural controls into consistently dependable, life-sustaining care, with a patient-first lens that remains steady under pressure.